You are here

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Hialeah, Florida, 33013 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Panic Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
13-17 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A primary DSM-IV-TR diagnosis of panic disorder with or without agoraphobia based on
the Mini International Neuropsychiatric Interview for Children and Adolescents

- At least an average of one 4-symptom panic attack per week over the last 4 weeks prior
to screening

- At least an average of one 4-symptom panic attack per week over the last 4 weeks prior
to baseline

- At least one 4-symptom panic attack in the 7 days prior to baseline

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Current (in the past 6 months) DSM-IV-TR diagnosis of obsessive compulsive disorder,
major depressive disorder, dysthymic disorder, or alcohol and/or substance dependence

- Primary DSM-IV-TR diagnosis of social anxiety disorder, post-traumatic stress
disorder, simple phobia, separation anxiety disorder, generalized anxiety disorder,
conduct disorder, oppositional defiant disorder, or attention deficit hyperactivity
disorder

- Any current or past history of schizophrenia or psychosis; bipolar disorder or
cyclothymia; dementia, delirium or other organic brain disease; an Axis I eating
disorder; mental retardation, Asperger's disorder, or any other serious developmental
disorder

- A CDRS-R score >35

NCT00635531
Pfizer
Terminated
A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now